H. Wilke

发表

Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.

M. Stuschke, M. Bitzer, W. Budach, 2017, European journal of cancer.

Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801).

F. Lordick, A. Tannapfel, S. Mönig, 2018, European journal of cancer.

Application of Adjuvant Chemotherapy in Colorectal Cancer – a Survey in the Region of Essen, Germany

C. Müller, M. Stahl, H. Wilke, 2004, Oncology Research and Treatment.

Colorectal cancer and metastasectomy: treatment of advanced disease.

M. Stahl, H. Wilke, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Irinotecan: New Results in the Combination Chemotherapy of Colorectal Cancer

U. Vanhoefer, M. Stahl, H. Wilke, 2000, Oncology Research and Treatment.

Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems

H. Kock, H. Wilke, F. Eigler, 1998, World Journal of Surgery.

[Therapy in gastric cancer. From an oncological perspective].

M. Stahl, H. Wilke, 2009, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: First results of a randomized phase III trial

M. Stuschke, N. Lehmann, M. Seegenschmiedt, 2007 .

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

M. Stuschke, N. Lehmann, M. Bitzer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy

C. Müller, M. Stahl, H. Wilke, 2005, Oncology Research and Treatment.

Second-line chemotherapy of advanced disseminated gastric cancer after cisplatin, infusional 5-fluorouracil, folinic acid (PLF): benefit dependent on progression-free interval after first-line therapy.

C. Müller, M. Stahl, H. Wilke, 2005, Onkologie.

Reaction after oxaliplatin--prevention with corticosteroids?

M. Stahl, H. Wilke, W. Köster, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Nils Lehmann, Martin Stuschke, S. Seeber, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer

U. Vanhoefer, S. Seeber, M. Stuschke, 2004, Journal of Cancer Research and Clinical Oncology.

[60-year-old patient with fever, jaundice and intra-abdominal lymphomas].

M. Stahl, H. Wilke, W. Köster, 2001, Medizinische Klinik.

Induction Chemotherapy followed by Concurrent Chemotherapy and High-Dose Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Cervical Oesophagus

H. Sack, S. Seeber, M. Stuschke, 1999, Oncology.

Long-term results of a phase III study investigating chemoradiation with and without surgery in locally advanced squamous cell carcinoma (LA-SCC) of the esophagus

M. Stuschke, N. Lehmann, M. Stahl, 2008 .

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

M. Freund, H. Schmoll, M. Stahl, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

G. Brittinger, D. Huhn, H. Gerhartz, 1984, Hematological oncology.

Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial.

H. Sack, H. Makoski, J. Siewert, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Answering patients' needs: oral alternatives to intravenous therapy.

W. Scheithauer, M. Borner, C. Twelves, 2001, The oncologist.

Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

V. Budach, H. Sack, L. Schlenger, 1999, British Journal of Cancer.

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

V. Budach, H. Sack, S. Seeber, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CHEMOTHERAPY OF GASTRIC CANCER.

S. Seeber, M. Stahl, H. Wilke, 1964, Acta - Unio Internationalis Contra Cancrum.

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

C. Bokemeyer, H. Schmoll, H. Schmoll, 1992, European journal of cancer.

Esophageal Cancer: Neoadjuvant therapy for squamous cell esophageal carcinoma

J. Siewert, J. Roder, H. Stein, 1994 .

Short report: High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study

C. Bokemeyer, H. Schmoll, M. Stahl, 1990 .

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

M. Stuschke, N. Lehmann, M. Bitzer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.

M. Stuschke, N. Lehmann, M. Stahl, 2012, European journal of cancer.